8-K: Current report filing
Published on April 29, 2010
SECURITIES
AND EXCHANGE COMMISSION
Washington,
DC 20549
FORM
8-K
CURRENT
REPORT
Pursuant
to Section 13 or 15(d) of the
Securities
Exchange Act of 1934
Date of
Report (Date of earliest event reported)
April
29, 2010
NEOGENOMICS,
INC.
(Exact
name of registrant as specified in its charter)
|
Nevada
|
333-72097
|
74-2897368
|
|
|
(State
or other jurisdiction of
|
(Commission
File Number)
|
(I.R.S.
Employer
|
|
|
incorporation)
|
Identification
No.)
|
||
|
12701 Commonwealth
Drive, Suite 9, Fort Myers, Florida
(Address
of principal executive offices)
|
33913
(Zip
Code)
|
||
(239)
768-0600
(Registrant’s
telephone number, including area code)
Check the
appropriate box below if the Form 8-K filing is intended to simultaneously
satisfy the filing obligation of the registrant under any of the following
provisions:
|
□
|
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425)
|
|
□
|
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
|
|
□
|
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR
240.14d-2(b))
|
|
□
|
Pre-commencement communications
pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR
240.13e-4(c))
|
On April
29, 2010, NeoGenomics, Inc. (the “Company”) issued a press release regarding the
Company’s results of operations for the quarter ended March 31, 2010. A copy of
the press release is furnished as Exhibit 99.1 to this Current Report on Form
8-K. This information shall not be deemed “filed” for purposes of Section 18 of
the Securities Exchange Act of 1934, as amended (“Exchange Act”) or incorporated
by reference in any filing under the Securities Act of 1933, as amended, or the
Exchange Act, except as shall be expressly set forth by specific reference in
such a filing.
Item
9.01. Financial Statements
and Exhibits.
(a) Not
applicable
(b) Not
applicable
(c) Not
applicable
(d) Exhibits.
|
99.1
|
Press
Release of NeoGenomics, Inc. dated April 29,
2010
|
-2-
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has
duly caused this report to be signed on its behalf by the undersigned hereunto
duly authorized.
| NEOGENOMICS, INC. | |||
|
|
By:
|
/s/ George Cardoza | |
| George Cardoza | |||
| Chief Financial Officer | |||
|
Date:
April 29, 2010
|
-3-
Exhibit
Index
|
Exhibit
No.
|
Description
|
|
|
99.1
|
Press
Release of NeoGenomics, Inc. dated April 29,
2010
|
-4-